Squarepoint Ops LLC Catalyst Biosciences, Inc. Transaction History

Squarepoint Ops LLC

  • $59.6 Billion
  • Q2 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$0.91 - $4.16 $23,229 - $106,192
-25,527 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$3.78 - $5.18 $81,394 - $111,540
-21,533 Reduced 45.76%
25,527 $105,000
Q2 2021

Aug 16, 2021
SELL
$4.1 - $5.33 $93,209 - $121,172
-22,734 Reduced 32.57%
47,060 $204,000
Q1 2021

May 17, 2021
BUY
$4.93 - $7.15 $344,084 - $499,027
69,794 New
69,794 $352,000
Q4 2020

Feb 16, 2021
SELL
$4.55 - $7.29 $131,754 - $211,096
-28,957 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$4.22 - $6.04 $30,240 - $43,282
-7,166 Reduced 19.84%
28,957 $125,000
Q2 2020

Aug 14, 2020
BUY
$3.76 - $8.01 $56,080 - $119,469
14,915 Added 70.33%
36,123 $212,000
Q1 2020

May 15, 2020
BUY
$3.5 - $8.51 $74,228 - $180,480
21,208 New
21,208 $93,000
Q3 2019

Nov 14, 2019
SELL
$4.91 - $9.31 $121,389 - $230,171
-24,723 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$7.08 - $10.6 $69,504 - $104,060
9,817 Added 65.86%
24,723 $182,000
Q1 2019

May 15, 2019
BUY
$7.67 - $9.96 $114,329 - $148,463
14,906 New
14,906 $121,000
Q4 2018

Feb 14, 2019
SELL
$6.59 - $11.28 $146,924 - $251,487
-22,295 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$9.35 - $12.44 $134,284 - $178,663
-14,362 Reduced 39.18%
22,295 $240,000
Q2 2018

Aug 14, 2018
BUY
$9.11 - $28.88 $333,945 - $1.06 Million
36,657 New
36,657 $428,000

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0
View Full List

About CATALYST BIOSCIENCES, INC.

CBIO Quotes by TradingView
  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email